INDICATIONS

• Pulseless cardiac arrest
• Symptomatic bradycardia
• Shock
• Severe asthma (status asthmaticus)

PRECAUTIONS

• May induce tachycardia
• Vasoconstriction
• May induce heart failure

DOSAGE & ADMINISTRATION

PULSELESS ARREST  IV/IO 0.01 mg/kg (0.1 mg/ml solution)

• Administer every 3–5 minutes during arrest
• IV/IO are the best routes. If not available, it can be administered endotracheally (ET): 0.1 mg/kg (1 mg/ml concentration),
• Administer every 3–5 minutes

ANAPHYLAXIS / SEVERE STATUS ASTHAMATICUS:

• IM: 0.01 mg/kg of the 1 mg/ml solution
• May repeat as needed

SYMPTOMATIC BRADYCARDIA:

• Titrated infusion: start at 0.1–1.0 mcg/kg/minute